Bartholomew R M, Podack E R, Esser A F
J Immunol Methods. 1979;31(3-4):351-60. doi: 10.1016/0022-1759(79)90148-0.
A sensitive assay of complement (C) activation via either the classical or alternative pathway was developed by evaluating assembly of the terminal complexes (C5b-9)2 or SC5b-9. Activation of serum containing [125I]C7 resulted in the formation of a stable, radiolabeled complex which was separable from its precursors by sedimentation in an air-driven ultracentrifuge. The radioactivity in the sediment was directly proportional to the amount of complex formed and assembly of the complex could be detected after C activation by aggregated IgG in concentrations as low as 10 micrograms/ml. Mild detergents such as Triton X-100 could be included in the reaction mixture, because they affected neither the assembly nor the integrity of the complexes. The assay, which detects both assembly of the membrane attack complex (MAC or (C5b-9)2) on target membranes and formation of SC5b-9 in fluid phase, measures the potential of certain substances to trigger the cytolytic phase of C regardless of whether the classical or alternative pathway was activated. However, by using serum depleted of either factor B or C1q, activation of either pathway can be assessed individually.
通过评估末端复合物(C5b-9)₂或SC5b-9的组装,开发了一种通过经典途径或替代途径检测补体(C)激活的灵敏检测方法。含有[¹²⁵I]C7的血清激活会导致形成一种稳定的放射性标记复合物,该复合物可通过在空气驱动的超速离心机中沉降与其前体分离。沉淀物中的放射性与形成的复合物量成正比,并且在低至10微克/毫升的聚集IgG激活补体后即可检测到复合物的组装。反应混合物中可加入温和的去污剂,如 Triton X-100,因为它们既不影响复合物的组装也不影响其完整性。该检测方法可检测膜攻击复合物(MAC或(C5b-9)₂)在靶膜上的组装以及液相中SC5b-9的形成,可测量某些物质引发补体溶细胞阶段的潜力,而无论激活的是经典途径还是替代途径。然而,通过使用缺乏因子B或C1q的血清,可以分别评估任一途径的激活情况。